YCBD
YCBD
AMEX · Pharmaceuticals

Cbdmd Inc

$0.57
+0.00 (+0.21%)
As of Aug 8, 2:32 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,825.0% upside
Low Target $15.39
Average Target $27.92
High Target $30.56
Current Price $0.57
Current
$0.57
Target
$27.92
$15.39 $27.92 avg $30.56
Scenario Analysis
Bear Case
$15.39
2,614.8%
Low target
Base Case
$27.92
+4,825.0%
Avg target
Bull Case
$30.56
+5,290.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.56
-77.9% from high
52-Week Low
$0.47
+21.9% from low
Target vs 52W High
$27.92
+990.6% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.03
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%